» Articles » PMID: 17963848

Anti-thyroperoxidase Antibodies from Patients with Hashimoto's Encephalopathy Bind to Cerebellar Astrocytes

Overview
Journal J Neuroimmunol
Specialty Neurology
Date 2007 Oct 30
PMID 17963848
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

A cohort of 10 Hashimoto's encephalopathy (HE) patients, 33 patients with unrelated neurological symptoms, 12 Hashimoto's thyroiditis patients and 4 healthy adult donors was studied to explore the neurological targets of anti-thyroperoxidase (TPO) autoantibodies (aAb) in HE. High levels of anti-TPO aAb were only detected in HE group's cerebrospinal fluids. In immunofluorescence assays on monkey brain cerebellum sections, both HE patients' sera and anti-TPO monoclonal antibodies (mAb) were able to bind cerebellar cells expressing glial fibrillary acid protein. Normal human astrocytes from primary cultures also reacted with anti-TPO mAb. Specific astrocyte binding of anti-TPO aAb suggests a role of these aAb in the HE pathogenesis.

Citing Articles

Difficulties in the Diagnostics and Treatment of Hashimoto's Encephalopathy-A Systematic and Critical Review.

Pempera N, Miedziaszczyk M, Lacka K Int J Mol Sci. 2024; 25(13).

PMID: 39000209 PMC: 11241003. DOI: 10.3390/ijms25137101.


Hashimoto's encephalopathy: an endocrinological point of view.

Croce L, Dal Molin M, Teliti M, Rotondi M Front Endocrinol (Lausanne). 2024; 15:1367817.

PMID: 38665262 PMC: 11044667. DOI: 10.3389/fendo.2024.1367817.


Autoimmune Encephalopathy Associated With Anti-thyroid Antibodies: A Case Report.

Falb V, Costanzo L, Avalos C, Feoktistov A Cureus. 2022; 14(8):e28183.

PMID: 36148192 PMC: 9482811. DOI: 10.7759/cureus.28183.


Hashimoto's encephalopathy with cerebellar ataxia as the main symptom: A case report and literature review.

Wei C, Shen Y, Zhai W, Shang T, Wang Z, Wang Y Front Neurol. 2022; 13:970141.

PMID: 36081870 PMC: 9445579. DOI: 10.3389/fneur.2022.970141.


Hashimoto's encephalopathy with psychiatric presentation.

Singh A, Verma L Ind Psychiatry J. 2022; 31(1):162-164.

PMID: 35800865 PMC: 9255614. DOI: 10.4103/ipj.ipj_61_20.